logo

Soleno Therapeutics Inc (SLNO)



Trade SLNO now with
  Date
  Headline
12/8/2017 8:10:00 AM Soleno Therapeutics Announces JV Agreement For Development And Commercialization Of CoSense Monitoring Technology
11/14/2017 8:12:03 AM Soleno Therapeutics Q3 Net Loss Narrows To $3.8 Mln Or $0.35/shr From $2.8 Mln Or $0.87/shr Last Year
10/12/2017 8:03:59 AM Soleno Therapeutics Receives Positive Opinion From European Orphan Committee For DCCR In Prader-Willi Syndrome
10/5/2017 1:11:05 PM Soleno Therapeutics Announces 1-for-5 Reverse Stock Split
9/15/2017 8:03:07 AM Soleno Therapeutics Presents Updated Safety And Efficacy Data From Clinical Trial Of DCCR For Prader-Willi Syndrome
9/13/2017 8:08:49 AM Soleno Therapeutics Reports Issuance Of New U.S. Patent For DCCR In Treatment Of Prader-Willi Syndrome
  
 
>